This inventor holds 77 USPTO granted patents and 25 published patent applications, plus 6 CIPO patents and 17 EPO patents, primarily in G-Protein Receptor Modulators (CPC class C07D). Top assignees: Vertex Pharmaceuticals, Inc., Escient Pharmaceuticals, Inc., Celgene International Ii Sarl. Active years: 2003-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Company Filing History:
41 out of 1,167 
12 out of 12 
10 out of 17 
Years Active: 2003-2025
Areas of Expertise:
Title: Esther Martinborough: Pioneer in MRGPRX2 Modulation
Introduction
Esther Martinborough is a notable inventor located in San Diego, California, whose contributions to the pharmaceutical field are significant. With a remarkable portfolio of 79 patents, her work primarily focuses on modulators of the mas-related G-protein receptor X2 (MRGPRX2) and its related products and methods.
Latest Patents
Among her latest patents, Martinborough has developed methods for modulating MRGPRX2 and treating conditions dependent on this receptor. These methods highlight the administration of an effective amount of a compound that interacts with MRGPRX2, including various forms such as salts, isomers, and isotopes. Her innovations also encompass pharmaceutical compositions containing these compounds, which are crucial for advancing medical treatments involving MRGPRX2.
Career Highlights
Throughout her career, Esther has been associated with leading pharmaceutical companies such as Vertex Pharmaceuticals, Inc. and Escient Pharmaceuticals, Inc. Her experience in these organizations has played a pivotal role in her development as an inventor, enabling her to apply her scientific knowledge in practical and groundbreaking ways.
Collaborations
Martinborough's career has seen her work alongside esteemed colleagues, including Andreas Peter Termin and Liming Huang. These collaborative efforts have led to significant advancements in research and the development of innovative therapies.
Conclusion
Esther Martinborough continues to be an influential figure in the field of pharmaceutical innovations. Her substantial number of patents reflects her dedication to research and her commitment to improving medical therapies for various conditions through MRGPRX2 modulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile